On Monday, Prime Medicine Inc (PRME) stock saw a decline, ending the day at $3.18 which represents a decrease of $-0.17 or -5.07% from the prior close of $3.35. The stock opened at $3.37 and touched a ...

Investment analysts at HC Wainwright decreased their FY2024 earnings per share (EPS) estimates for Prime Medicine in a ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Prime Medicine, Inc. (PRME – Research Report), ...

H.C. Wainwright analyst Arthur He CFA maintained a Buy rating on Prime Medicine, Inc. (PRME – Research Report) today and set a price target of $10.00. Arthur He CFA has given his Buy rating due to a ...

So, the natural question for Prime Medicine (NASDAQ:PRME) shareholders is whether they should be concerned by its rate of cash burn. For the purposes of this article, cash burn is the annual rate ...

Prime Medicine, Inc. ( (PRME)) has released its Q3 earnings. Here is a breakdown of the information Prime Medicine, Inc. presented to its investors. Prime Medicine, Inc. is a biotechnology company ...

CAMBRIDGE, Mass. - Prime Medicine, Inc. (NASDAQ:PRME), a biotechnology firm, has finalized an upsized public offering, raising gross proceeds of approximately $161 million, the... Prime Medicine ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

"The prime minister has been extremely busy working until late into the night, and I understand that he had a cold today and was taking cold medicine." ...

Prime Minister Justin Trudeau today announced the appointment of a former journalist and women’s rights advocate as the next ...

Prime Minister Justin Trudeau says the federal government could have acted faster on reining in immigration programs, after ...